000 | 01255 a2200373 4500 | ||
---|---|---|---|
005 | 20250512020404.0 | ||
264 | 0 | _c19890427 | |
008 | 198904s 0 0 eng d | ||
022 | _a0029-7844 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaeger, M | |
245 | 0 | 0 |
_aComplement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid. _h[electronic resource] |
260 |
_bObstetrics and gynecology _cApr 1989 |
||
300 |
_a551-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAmniotic Fluid _ximmunology |
650 | 0 | 4 |
_aAnaphylatoxins _xbiosynthesis |
650 | 0 | 4 | _aComplement Activation |
650 | 0 | 4 |
_aComplement C3 _xanalogs & derivatives |
650 | 0 | 4 | _aComplement C3a |
650 | 0 | 4 |
_aComplement C5 _xanalogs & derivatives |
650 | 0 | 4 | _aComplement C5a |
650 | 0 | 4 | _aComplement C5a, des-Arginine |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPeptide Biosynthesis |
650 | 0 | 4 |
_aPre-Eclampsia _ximmunology |
650 | 0 | 4 |
_aPregnancy _ximmunology |
700 | 1 | _aBengtson, A | |
700 | 1 | _aKarlsson, K | |
700 | 1 | _aHeideman, M | |
773 | 0 |
_tObstetrics and gynecology _gvol. 73 _gno. 4 _gp. 551-6 |
|
999 |
_c2790421 _d2790421 |